University of North Carolina Lineberger Comprehensive Cancer Center’s Multiple Myeloma & Amyloidosis Program
The University of North Carolina (UNC) Lineberger Comprehensive Cancer Center’s Multiple Myeloma & Amyloidosis Program treats multiple myeloma, amyloidosis and other plasma cell-related disorders such as solitary plasmacytoma, POEMS syndrome, monoclonal gammopathy of uncertain significance (MGUS), asymptomatic “smoldering” myeloma and Castleman’s disease.
UNC’s Multiple Myeloma and Amyloidosis Program offers patients and referring physicians access to a complete range of both diagnostic and therapeutic services for multiple myeloma and other plasma cell disorders. These include chemotherapy, radiation therapy and stem cell transplantation. Multiple specialists are part of our team, helping you manage side effects and symptoms of your condition and treatment side effects.
Due to the complicated nature of these disorders, our multidisciplinary approach, with input from experts from a number of specialties, allows us to excel in treating these patients. We ensure that expertly developed care is individualized for each patient and delivered in a well-coordinated and caring manner by incorporating specialists from hematology, medical, radiation oncology, pathology, UNC Imaging and Spine Center, the Bone Marrow Transplant and Cellular Therapy Program, radiology, and oncology nursing into a single patient care team.
The team includes healthcare professionals in the following areas:
Hematology and Oncology:
Sascha Tuchman, MD, MHS
